###begin article-title 0
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: BDF MR. Performed the experiments: ADB BDF ED TCT PL. Analyzed the data: ADB BDF ED TCT PL IRN MR. Contributed reagents/materials/analysis tools: CP. Wrote the paper: ADB BDF MR.
###end p 1
###begin p 2
Current address: Albert Einstein College of Medicine, Bronx, New York, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 323 328 <span type="species:ncbi:9606">human</span>
Mammalian target of rapamycin complex 1 (mTORC1) is a protein kinase that relays nutrient availability signals to control numerous cellular functions including autophagy, a process of cellular self-eating activated by nutrient depletion. Addressing the therapeutic potential of modulating mTORC1 signaling and autophagy in human disease requires active chemicals with pharmacologically desirable properties.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 1000 1005 <span type="species:ncbi:10090">mouse</span>
Using an automated cell-based assay, we screened a collection of >3,500 chemicals and identified three approved drugs (perhexiline, niclosamide, amiodarone) and one pharmacological reagent (rottlerin) capable of rapidly increasing autophagosome content. Biochemical assays showed that the four compounds stimulate autophagy and inhibit mTORC1 signaling in cells maintained in nutrient-rich conditions. The compounds did not inhibit mTORC2, which also contains mTOR as a catalytic subunit, suggesting that they do not inhibit mTOR catalytic activity but rather inhibit signaling to mTORC1. mTORC1 inhibition and autophagosome accumulation induced by perhexiline, niclosamide or rottlerin were rapidly reversed upon drug withdrawal whereas amiodarone inhibited mTORC1 essentially irreversibly. TSC2, a negative regulator of mTORC1, was required for inhibition of mTORC1 signaling by rottlerin but not for mTORC1 inhibition by perhexiline, niclosamide and amiodarone. Transient exposure of immortalized mouse embryo fibroblasts to these drugs was not toxic in nutrient-rich conditions but led to rapid cell death by apoptosis in starvation conditions, by a mechanism determined in large part by the tuberous sclerosis complex protein TSC2, an upstream regulator of mTORC1. By contrast, transient exposure to the mTORC1 inhibitor rapamycin caused essentially irreversible mTORC1 inhibition, sustained inhibition of cell growth and no selective cell killing in starvation.
###end p 6
###begin title 7
Conclusion/Significance
###end title 7
###begin p 8
###xml 48 53 <span type="species:ncbi:9606">human</span>
The observation that drugs already approved for human use can reversibly inhibit mTORC1 and stimulate autophagy should greatly facilitate the preclinical and clinical testing of mTORC1 inhibition for indications such as tuberous sclerosis, diabetes, cardiovascular disease and cancer.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 548 551 548 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Yoshimori1">[1]</xref>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Klionsky1">[2]</xref>
###xml 700 703 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wullschleger1">[3]</xref>
###xml 862 865 862 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang1">[4]</xref>
###xml 867 870 867 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kundu1">[5]</xref>
The cellular processes linked to growth are tightly modulated by nutrient levels. Anabolic functions such as ribosome biogenesis and protein synthesis are inhibited under conditions of nutrient limitation, while catabolic pathways such as autophagy are activated. Autophagy, a process of cellular self-eating, can temporarily compensate for lack of extracellular nutrients by engulfing cytoplasmic components within double-membraned autophagosomes, degrading them by fusion with lysosomes and releasing building blocks for macromolecular synthesis [1], [2]. Mammalian target of rapamycin complex 1 (mTORC1) plays a critical role in coupling nutrient sensing to these anabolic and catabolic processes [3]. When nutrients are available, mTORC1 is switched on and negatively regulates autophagy while positively regulating ribosome biogenesis and protein synthesis [4], [5]. Conversely, nutrient limitation turns off mTORC1 signaling, leading to inhibition of cell growth and stimulation of autophagy.
###end p 10
###begin p 11
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wullschleger1">[3]</xref>
###xml 266 269 266 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Brunn1">[6]</xref>
###xml 271 274 271 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Hara1">[7]</xref>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Burnett1">[8]</xref>
###xml 716 719 716 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wullschleger1">[3]</xref>
###xml 1086 1089 1086 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Ruvinsky1">[9]</xref>
mTORC1 is a protein complex composed of the serine/threonine kinase mTOR, the scaffolding protein raptor and mLST8 [3]. mTORC1 controls the initiation step of protein synthesis through the phosphorylation of eukaryotic initiation factor 4E-binding proteins (4E-BPs) [6], [7] and of ribosomal S6 kinases (S6Ks) [8]. 4E-BPs are a family of small proteins that associate with eIF4E, an mRNA cap-binding protein. eIF4E, together with eIF4G and eIF4A form the eIF4F complex that recruits the small (40S) ribosomal subunit to the 5'-end of mRNA. 4E-BPs and eIF4G bind to overlapping regions in eIF4E such that binding of 4E-BPs to eIF4E precludes the binding of eIF4G and blocks recruitment of the ribosome to the message [3]. The binding of 4E-BP1 to eIF4E is blocked through mTORC1-dependent phosphorylation of multiple residues on 4E-BP1. mTORC1 also phosphorylates the S6Ks that in turn phosphorylate multiple translation components including eIF4B and ribosomal protein S6. However, the role of phosphorylation of these proteins in stimulating protein synthesis remains to be elucidated [9].
###end p 11
###begin p 12
###xml 127 137 127 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Scott1">[10]</xref>
###xml 312 322 312 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Scott1">[10]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kamada1">[11]</xref>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Cheong1">[12]</xref>
###xml 769 773 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kamada1">[11]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Chan1">[13]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Hosokawa1">[14]</xref>
###xml 1049 1062 1049 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 1067 1082 1067 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D. melanogaster</italic>
###xml 1082 1086 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kamada1">[11]</xref>
###xml 1088 1092 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Blommaart1">[15]</xref>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Rusten1">[17]</xref>
###xml 432 437 <span type="species:ncbi:4932">yeast</span>
###xml 786 791 <span type="species:ncbi:9606">human</span>
###xml 1049 1062 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1067 1082 <span type="species:ncbi:7227">D. melanogaster</span>
Studies in metazoans and lower eukaryotes indicate that TORC1 plays an important role in the control of autophagy. Deletion in Drosophila of TOR or Rheb, an activator of TORC1, enhances autophagy even under the nutrient-rich conditions in which autophagy is typically downregulated [10]. Conversely, deletion of Drosophila TSC2, an inhibitor of Rheb/TORC1 signaling, blocks autophagy induced by nutrient withdrawal [10]. In budding yeast, TOR has been proposed to inhibit autophagy through phosphorylation of the Atg1/Atg13 complex [11], which regulates the recruitment of proteins to, and development of, nascent autophagosomes [12]. Phosphorylation of Atg13 by TOR precludes the binding of Atg13 to Atg1, resulting in a marked decrease in the kinase activity of Atg1 [11]. A putative human homologue of Atg13 has been identified [13] that forms a complex with ULK1 and FIP200 that may be directly regulated by mTORC1 [14]. In keeping with genetic data, rapamycin, a specific inhibitor of mTORC1, induces autophagy in mammalian cells as well as in S. cerevisiae and D. melanogaster[11], [15]-[17].
###end p 12
###begin p 13
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kundu1">[5]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kondo1">[18]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kundu1">[5]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kondo1">[18]</xref>
###xml 663 666 663 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kundu1">[5]</xref>
In addition to promoting cell survival in starvation conditions, autophagy plays a key role in cellular homeostasis by degrading long-lived proteins, damaged organelles and abnormal protein aggregates whose accumulation can lead to cell death, muscular- and neuro-degenerative diseases and cancer [5], [18]. Defects in autophagy may contribute to tumorigenesis, by allowing the accumulation of damaged mitochondria, which can lead to genetic instability [5]. Autophagy is also frequently observed in dying cells, prompting the suggestion that it can constitute a death mechanism [18]. Therefore, defects in autophagy could also contribute to cancer cell survival [5].
###end p 13
###begin p 14
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Klionsky1">[2]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-LeTourneau1">[19]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Rubinsztein1">[20]</xref>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 470 476 <span type="species:ncbi:9606">humans</span>
###xml 1084 1089 <span type="species:ncbi:9606">human</span>
Addressing the therapeutic potential of modulating mTORC1 signaling and autophagy in human disease requires active chemicals with pharmacologically desirable properties [2], [19], [20]. We have developed an assay to detect chemicals that cause a rapid increase in cellular autophagosome content. A screen of >3,500 approved and off-patent medications, as well as compounds with known pharmacological activity led to the identification of three drugs approved for use in humans (amiodarone, niclosamide and perhexiline) and the pharmacological agent rottlerin. Consistent with their ability to modulate autophagy, we show that these chemicals also control mTORC1 signaling. Rottlerin inhibits mTORC1 signaling via TSC2 while the other drugs inhibit mTORC1 signaling in a TSC2-independent manner. Transient exposure to niclosamide, perhexiline or rottlerin causes reversible inhibition of mTORC1 signaling and is not toxic to cells in conditions of nutrient and growth factor sufficiency. However, these drugs selectively kill cells in starvation conditions. Drugs already approved for human use that can reversibly inhibit mTORC1 signaling and stimulate autophagy are valuable pharmacological tools to evaluate the therapeutic potential of manipulating mTORC1 and autophagy in disease.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Development of an automated microscopy screen for chemical modulators of autophagy
###end title 16
###begin p 17
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Xie1">[21]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kabeya1">[22]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Ichimura1">[24]</xref>
###xml 582 589 582 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g001">Fig. 1a</xref>
###xml 788 795 788 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g001">Fig. 1b</xref>
###xml 940 947 940 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g001">Fig. 1b</xref>
###xml 963 972 963 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s001">Figure S1</xref>
###xml 1024 1028 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Meijer1">[25]</xref>
###xml 1398 1402 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang1">[26]</xref>
###xml 1461 1468 1461 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s002">Fig. S2</xref>
###xml 1625 1633 1625 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s001">Fig. S1b</xref>
###xml 455 460 <span type="species:ncbi:9606">human</span>
Upon autophagy induction, the cytosolic Atg8 protein, also called LC3, is recruited to the membrane of nascent autophagosomes and controls autophagosome expansion [21]. LC3 is synthesised as a precursor protein whose C-terminus is cleaved by a cysteine protease to expose a glycine residue that is subsequently conjugated to phosphatidylethanolamine by a ubiquitin-like system [22]-[24]. To develop a screening assay for chemical modulators of autophagy, human breast cancer MCF-7 cells were stably transfected with a plasmid for expression of LC3 linked at its N-terminus to EGFP (Fig. 1a). In complete cell culture medium containing glucose, amino acids and serum, EGFP-LC3 fluorescence was largely diffuse throughout the cytoplasm with few dots denoting basal autophagosome formation (Fig. 1b). The number of EGFP-LC3 dots rapidly increased within 4 h exposure to the mTORC1 inhibitor rapamycin, or to amino acid- and serum-free medium (Fig. 1b; Supplementary Figure S1), conditions that are known to stimulate autophagy [25]. We wished to identify chemicals that, like rapamycin and starvation, also rapidly increase EGFP-LC3 punctate staining in cells maintained in nutrient-rich conditions, where autophagy is normally downregulated. The microscopy assay was automated using a high-content screening instrument programmed to detect and quantitate punctate EGFP-LC3 fluorescence. The Z-factor [26] for the assay was 0.55, appropriate for use in screening (Fig. S2). As demonstrated by the automated assay, withdrawal of amino acids and serum for 4 h caused a 3-fold increase in punctate EGFP-LC3 fluorescence intensity (Fig. S1b).
###end p 17
###begin title 18
Cell-based assay for the identification of chemical modulators of autophagy and identification of amiodarone, niclosamide, perhexiline and rottlerin as modulators of autophagy.
###end title 18
###begin p 19
###xml 463 484 463 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
(a) Schematic representation of the EGFP-LC3 puncta formation assay used to screen for chemical modulators of autophagy. (b) Punctate EGFP-LC3 accumulation upon treatment with rapamycin or nutrient deprivation. MCF-7 cells stably expressing EGFP-LC3 were incubated without or with 20 nM rapamycin in complete cell culture medium or in medium lacking serum and amino acids for 4 h. EGFP-LC3 punctate staining was visualised by automated microscopy as described in Materials and Methods. (c) Chemical structures of perhexiline, niclosamide, amiodarone and rottlerin. (d) Quantitation of punctate EGFP-LC3 accumulation upon incubation with the active chemicals. MCF-7 cells stably expressing EGFP-LC3 were incubated for 4 h with different concentrations of the chemicals and EGFP-LC3 puntacte staining was quantitated using the automated microscopy assay.
###end p 19
###begin p 20
###xml 370 378 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s002">Fig. S2b</xref>
###xml 456 463 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g001">Fig. 1c</xref>
###xml 616 623 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g001">Fig. 1d</xref>
A collection of 3,584 drugs and pharmacologically active chemicals was tested at a concentration of approximately15 microM for 4 h in complete cell culture medium. Chemicals causing a >/=80% reduction in cell number were considered overtly toxic and were disregarded. Compounds that induced a >/=3-fold increase in punctate EGFP-LC3 intensity were designated as active (Fig. S2b). Four active chemicals, perhexiline, niclosamide, amiodarone and rottlerin (Fig. 1c), showed concentration-dependent activity ranging from 7- to 15-fold increased punctate EGFP-LC3 fluorescence intensity at their optimal concentration (Fig. 1d).
###end p 20
###begin p 21
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang2">[27]</xref>
###xml 196 200 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Sarkar1">[28]</xref>
###xml 374 378 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Song1">[29]</xref>
###xml 184 189 <span type="species:ncbi:9606">human</span>
Amiodarone has previously been found to reduce the accumulation of expanded polyglutamine aggregates [27] and to enhance the clearance of mutant huntingtin and A53T alpha-synuclein in human cells [28], likely through the stimulation of autophagy. Rottlerin has recently been reported to induce autophagy in a PKCpartial differential-independent manner in fibrosarcoma cells [29]. To our knowledge, neither niclosamide nor perhexiline have been previously reported to modulate autophagy.
###end p 21
###begin title 22
Characterization of amiodarone, rottlerin, niclosamide and perhexiline as stimulators of autophagy
###end title 22
###begin p 23
###xml 358 364 358 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g002">Fig. 2</xref>
###xml 564 570 564 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g002">Fig. 2</xref>
To verify that the punctate EGFP-LC3 fluorescence induced by the four chemicals represented autophagosome formation rather than, for instance, fluorescent drug precipitates, EGFP-LC3 fluorescence was examined at higher resolution by laser confocal microscopy. As expected, non-treated cells showed diffuse EGFP-LC3 fluorescence with few punctate structures (Fig. 2). Incubation with perhexiline, niclosamide, amiodarone or rottlerin for 4 h induced the appearance of a large number of EGFP-LC3-labeled cytoplasmic vesicles consistent with autophagosome formation (Fig. 2).
###end p 23
###begin title 24
Visualization of punctate EGFP-LC3 in cells treated with autophagy-modulating compounds.
###end title 24
###begin p 25
MCF-7 cells stably expressing EGFP-LC3 were treated for 4 h with DMSO (control), 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone or 3 microM rottlerin. Photographs show stacks of confocal sections spanning the entire cell thickness.
###end p 25
###begin p 26
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Yang1">[30]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Ding1">[31]</xref>
###xml 895 903 895 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s001">Fig. S1b</xref>
###xml 981 989 981 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s001">Fig. S1a</xref>
###xml 1069 1077 1069 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s003">Fig. S3a</xref>
To ensure that punctate fluorescence detected in drug-treated cells was due to modulation of autophagy, we next monitored EGFP-LC3 processing and degradation. Recruitment of LC3 to nascent autophagosomes involves its proteolytic cleavage and lipidation [30]. This processing step, which also occurs with EGFP-LC3, yields a polypeptide (EGFP-LC3II) with increased electrophoretic mobility. When autophagosomes fuse with lysosomes, EGFP-LC3II is degraded by lysosomal hydrolases and the labile LC3II moiety is degraded faster than the more stable EGFP moiety, leading to transient accumulation of EGFP, which is also eventually degraded [31]. The EGFP-LC3II and EGFP bands can therefore be considered as characteristic proteolytic intermediates in autophagy. A time-dependent accumulation of free EGFP was readily observed upon incubation of MCF-7 cells stably expressing EGFP-LC3 with rapamycin (Fig. S1b), consistent with the observed time-dependent increase in punctate EGFP-LC3 (Fig. S1a). Similarly, serum deprivation caused an accumulation of free EGFP within 1 h (Fig. S3a). To verify that the four active chemicals indeed modulated autophagy, we examined the appearance of these bands following incubation with a range of concentrations of the chemicals and for different times.
###end p 26
###begin p 27
###xml 139 145 135 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 314 320 306 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 459 465 451 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 569 576 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4b</xref>
###xml 634 641 626 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4c</xref>
###xml 643 645 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">5a</xref>
###xml 726 732 714 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 734 736 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">5a</xref>
###xml 755 762 743 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4c</xref>
###xml 943 949 927 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1061 1068 1045 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4d</xref>
Incubation with perhexiline at varying concentrations (3 to 10 microM) for 4 h caused a concentration-dependent accumulation of free EGFP (Fig. 3, top panel) as well as a small but appreciable increase in EGFP-LC3 lipidation. Niclosamide led to the accumulation of EGFP-LC3II at concentrations as low as 1 microM (Fig. 3, top panel). Free EGFP did not accumulate, but faster migrating bands corresponding to EGFP proteolysis products were readily detectable (Fig. 3). Lipidated EGFP-LC3 (EGFP-LC3II) was detected within 15 min and it continued to accumulate over time (Fig. 4b). Amiodarone also led to the accumulation of EGFP-LC3II (Fig. 4c, 5a) and a substantial increase in free EGFP at 10 microM or higher concentrations (Fig. 3, 5a) within 2 to 4 h (Fig. 4c). Like niclosamide and amiodarone, rottlerin caused the accumulation of EGFP-LC3II and free EGFP, as well as proteolytic fragments of EGFP at 0.3 microM and higher concentrations (Fig. 3). Lipidated EGFP-LC3 was visible within 30 min incubation while free EGFP could be detected between 2 and 4 h (Fig. 4d).
###end p 27
###begin title 28
Concentration-dependent stimulation of EGFP-LC3 processing and inhibition of mTORC1 signaling by perhexiline, niclosamide, amiodarone and rottlerin.
###end title 28
###begin p 29
###xml 285 288 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
MCF-7 cells stably expressing EGFP-LC3 were treated for 4 h with chemicals at the indicated concentrations or with 20 nM rapamycin. EGFP-LC3 processing was monitored by probing lysates with anti-GFP antibody, mTORC1 activity by probing lysates with antisera against phosphorylated (Thr389) S6K and total S6K, and mTORC2 activity with antisera against phosphorylated (Ser473) PKB/Akt and total PKB/Akt. beta-tubulin immunostaining was used as a protein loading control.
###end p 29
###begin title 30
Time-dependent stimulation of EGFP-LC3 processing and inhibition of mTORC1 signaling by perhexiline, niclosamide, amiodarone and rottlerin.
###end title 30
###begin p 31
MCF-7 cells stably expressing EGFP-LC3 were treated for the indicated times with 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone or 3 microM rottlerin. Immunoblotting was carried out using the antisera indicated.
###end p 31
###begin title 32
Effect of bafilomycin A1 on EGFP-LC3 processing and inhibition of mTORC1 signaling by perhexiline, niclosamide, amiodarone and rottlerin.
###end title 32
###begin p 33
MCF-7 cells stably expressing EGFP-LC3 were treated for 4 h with 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone or 3 microM rottlerin without or with 100 nM bafilomycin A1.
###end p 33
###begin p 34
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Sarkar2">[32]</xref>
###xml 517 523 517 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">Fig. 5</xref>
Bafilomycin A1 is an inhibitor of the vacuolar-type H+-ATPase that prevents lysosomal acidification, leading to inhibition of lysosomal hydrolases and fusion of autophagosomes with lysosomes [32]. Cells were next incubated with perhexiline, niclosamide, amiodarone, rottlerin or rapamycin in the absence or presence of bafilomycin A1 and EGFP-LC3 processing and degradation was monitored by western blotting. Bafilomycin A1 clearly blocked the accumulation of free EGFP by the four active chemicals and by rapamycin (Fig. 5), indicating that EGFP-LC3 proteolysis required autophagosome-lysosome fusion and lysosomal hydrolase activity. The observation that all four chemicals stimulated the processing and degradation of EGFP-LC3 in a bafilomycin A1-dependent manner is strong evidence that the chemicals increase autophagic flux and therefore stimulate autophagy.
###end p 34
###begin title 35
Perhexiline, niclosamide, amiodarone and rottlerin inhibit mTORC1 signaling
###end title 35
###begin p 36
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Chen1">[33]</xref>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Burnett1">[8]</xref>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 443 451 443 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s001">Fig. S1c</xref>
###xml 692 698 692 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 699 699 699 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004"/>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">5</xref>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 780 783 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 798 804 794 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 844 850 840 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4</xref>
###xml 970 976 958 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1087 1093 1075 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4</xref>
###xml 1244 1250 1224 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1307 1313 1287 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4</xref>
###xml 1424 1430 1396 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1473 1479 1445 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g004">Fig. 4</xref>
Autophagy is regulated through both mTORC1-dependent and -independent mechanisms [33]. Since perhexiline, niclosamide, amiodarone and rottlerin stimulate autophagy, we next asked whether any of these chemicals inhibited mTORC1 signaling. mTORC1 phosphorylates S6Ks at Thr389[8]. S6K phosphorylation was completely inhibited by rapamycin, as shown by a disappearance of the phospho-Thr389 signal and increased electrophoretic mobility of S6Ks (Fig. S1c). Samples of MCF-7 cells treated with the four chemicals at different concentrations or for different times were analyzed for mTORC1 activation. MCF-7 cells showed robust mTORC1 activation in complete medium containing serum and nutrients (Fig. 3-5). Perhexiline caused strong inhibition of the phosphorylation of p70S6K and p85S6K at 10 microM (Fig. 3) within 30 min and was maximal at 4 h (Fig. 4). Niclosamide caused a strong reduction of S6K phosphorylation at 1 microM and complete inhibition at 3 and 10 microM (Fig. 3). Partial inhibition was detectable as early as 5 min after treatment and was essentially complete after 2 h (Fig. 4). Amiodarone was the least potent of the compounds, with partial inhibition of S6K phosphorylation at 30 microM and complete inhibition at 50 microM (Fig. 3) and this effect was only readily detectable after 2 h (Fig. 4). Rottlerin caused partial inhibition of S6K phosphorylation at 1 microM and complete inhibition at 3 microM (Fig. 3). Inhibition was detectable within 2-4 h (Fig. 4).
###end p 36
###begin p 37
###xml 96 101 96 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g006">Fig. 6a</xref>
###xml 446 451 446 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g006">Fig. 6a</xref>
###xml 510 512 510 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 589 594 589 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang2">[34]</xref>
###xml 772 777 772 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 970 975 970 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 1023 1031 1023 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007124.s003">Fig. S3b</xref>
mTORC1 signaling also mediates the phosphorylation of multiple residues on 4E-BP1, including Thr37/46 and Ser65. Perhexiline, niclosamide, amiodarone and rottlerin, but not DMSO, strongly inhibited phosphorylation at Ser65 at 1 h and completely abolished it at 4 h as judged by the decreased binding of phospho-specific antibody and increased electrophoretic mobility of 4E-BP1 (Fig. 6a). These chemicals also decreased the phosphorylation of Thr37/46 in 4E-BP1 and 4E-BP2 (Fig. 6a). The phosphorylation of Ser65 requires both amino acids and growth factors, whereas phosphorylation of Thr37/46 is strongly stimulated by amino acids alone [34]. To examine whether perhexiline, niclosamide, amiodarone and rottlerin inhibited the amino acid-dependent phosphorylation of Thr37/46, MCF-7 cells were exposed to perhexiline, rottlerin, amiodarone or niclosamide in medium lacking serum for 1 h or 4 h. All four chemicals reduced the amino acid-mediated phosphorylation of Thr37/46 in 4E-BP1 and 4E-BP2, although not completely (Fig. S3b).
###end p 37
###begin title 38
Inhibition of 4E-BP phosphorylation and function by perhexiline, niclosamide, amiodarone and rottlerin.
###end title 38
###begin p 39
###xml 309 315 293 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 378 383 362 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 390 392 374 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 465 466 449 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 510 531 494 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
MCF-7 cells stably expressing EGFP-LC3 were incubated with 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone, 3 microM rottlerin or DMSO for 1 h or 4 h in complete medium. (a) EGFP-LC3 processing and mTORC1 and mTORC2 activation were monitored by immunoblotting as described in the legend to Fig. 3. Lysates were also probed with antisera to phosphorylated (Thr37/46 or Ser65) 4E-BPs and total 4E-BP1. (b) eIF4E was purified from cell extracts by m7GTP affinity chromatography as described in Materials and Methods and the purified material was probed with antisera against eIF4E, eIF4G and 4E-BP1.
###end p 39
###begin p 40
###xml 156 158 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Karim1">[35]</xref>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 940 947 940 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g006">Fig. 6b</xref>
###xml 1071 1074 1071 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang1">[4]</xref>
###xml 1216 1223 1216 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g006">Fig. 6b</xref>
Hypophosphorylated 4E-BPs bind to eIF4E thereby precluding the association of eIF4E with eIF4G and the assembly of the eIF4F complex. Phosphorylation of Ser65 has been suggested to be particularly important in preventing the re-association of 4E-BP1 with eIF4E [35]. Since the four active chemicals completely block phosphorylation of Ser65 in 4E-BP1, we next analyzed their effect on the binding of 4E-BPs to eIF4E by affinity chromatography. MCF-7 cells were propagated in complete medium to near-confluence and then incubated with perhexiline, niclosamide, amiodarone, rottlerin or DMSO (vehicle) for 4 h. Cellular extracts were incubated with 7-methylguanosine-5'-triphosphate beads and the pull-down material probed with antisera against eIF4E, eIF4G and 4E-BP1 in a western blot. In nutrient-rich conditions, where mTORC1 signaling is switched on and 4E-BP1 is hyperphosphorylated, eIF4E associates tightly with eIF4G but not 4E-BP1 (Fig. 6b, lane 6). Inhibition of mTORC1 by rapamycin increases the binding of 4E-BPs to eIF4E with the concomitant release of eIF4G [4]. Similarly, each of the four chemicals increased the binding of 4E-BP1 to eIF4E and partially decreased the association of eIF4G with eIF4E (Fig. 6b).
###end p 40
###begin p 41
###xml 212 218 212 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">Fig. 5</xref>
###xml 280 286 280 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g005">Fig. 5</xref>
The four active chemicals and rapamycin also inhibited mTORC1 signaling equally strongly in the absence or in the presence of bafilomycin A1, even though the latter inhibited EGFP-LC3 processing and degradation (Fig. 5). Moreover, bafilomycin A1 did not inhibit mTORC1 signaling (Fig. 5).
###end p 41
###begin p 42
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang3">[36]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Moschella1">[37]</xref>
###xml 387 390 <span type="species:ncbi:10116">rat</span>
###xml 395 398 <span type="species:ncbi:9685">cat</span>
Therefore, the four active chemicals inhibit mTORC1 signaling at concentrations that closely parallel those at which they stimulate autophagosome formation as well as EGFP-LC3 processing and degradation. To our knowledge, perhexiline, niclosamide and amiodarone have not previously been shown to inhibit mTORC1 signaling. Rottlerin was previously found to inhibit S6K phosphorylation in rat and cat cardiomyocytes [36], [37]. Perhexiline, amiodarone and rottlerin inhibited mTORC1 signaling much more slowly than rapamycin, which caused complete inhibition within 5 min (not shown), suggesting that they do not inhibit mTORC1 directly. The onset of mTORC1 signaling inhibition by niclosamide was rapid (5 min) but complete inhibition required a longer incubation. The observation that bafilomycin A1 inhibits EGFP-LC3 processing and degradation but that it does not affect the inhibition of mTORC1 signaling by the four active chemicals shows that mTORC1 signaling inhibition is not a consequence of stimulation of autophagy and is consistent with stimulation of autophagy lying downstream of mTORC1 inhibition.
###end p 42
###begin title 43
Perhexiline, niclosamide, amiodarone and rottlerin do not inhibit mTORC2 signaling
###end title 43
###begin p 44
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Burnett1">[8]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Oshiro1">[38]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang4">[40]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Sarbassov1">[41]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-GarciaMartinez1">[43]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Harrington1">[44]</xref>
###xml 612 615 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Shah1">[45]</xref>
###xml 827 830 827 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Harrington1">[44]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Shah1">[45]</xref>
###xml 1082 1086 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lin1">[46]</xref>
###xml 1088 1092 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Liang1">[47]</xref>
###xml 1133 1136 1133 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1217 1223 1217 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1225 1226 1225 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g006">6</xref>
###xml 1256 1259 1256 1259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 1382 1388 1382 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g003">Fig. 3</xref>
###xml 1471 1474 1471 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
mTOR is present in two distinct complexes: mTOR complex 1 (mTORC1) which phosphorylates S6Ks, 4E-BPs and PRAS40 [8], [38]-[40] and mTORC2 which catalyzes the phosphorylation of PKB/Akt and SGK1 [41]-[43]. Insulin receptor substrate-1 (IRS-1), and to a lesser extent IRS-2, protein levels are regulated by S6K1. Hyperactivation of S6K1 signaling leads to transcriptional inhibition of the IRS-1 gene and degradation of IRS-1 and IRS-2 proteins [44]. This is evident in both TSC1 and TSC2 null mouse embryo fibroblasts (MEFs) which exhibit reduced insulin receptor/PI3K signaling and PKB/Akt phosphorylation at Ser473 as a result of mTORC1/S6K1 signaling hyperactivation [45]. Prolonged treatment (24 h) of cells that display elevated mTORC1/S6K signaling with rapamycin restores PI3K signaling and PKB/Akt phosphorylation on Ser473[44], [45]. We reasoned that other inhibitors of mTORC1/S6K signaling, such as those identified in this screen, might also increase PKB/Akt phosphorylation. As predicted, MCF-7 cells, which exhibit elevated mTORC1 signaling like TSC1 or TSC2 null MEFs [46], [47], showed increased phosphorylation of Ser473 in PKB/Akt when treated with niclosamide, perhexiline, amiodarone or rottlerin (Fig. 3, 6). The increase in PKB/Akt Ser473 phosphorylation closely paralleled the decrease in mTORC1 activity as a function of concentration for the four chemicals (Fig. 3). The observation that the four chemicals increased PKB/Akt phosphorylation at Ser473 instead of decreasing it shows that they inhibited mTORC1 but not mTORC2 signaling.
###end p 44
###begin title 45
Reversibility of mTORC1 signaling inhibition and autophagosome accumulation
###end title 45
###begin p 46
###xml 380 383 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S6K</sup>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 406 413 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g007">Fig. 7a</xref>
###xml 571 578 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g007">Fig. 7a</xref>
###xml 1096 1103 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g007">Fig. 7b</xref>
MCF-7 cells expressing EGFP-LC3 were incubated with perhexiline, niclosamide, rottlerin, or amiodarone for 4 h in complete medium, the chemicals were washed away and S6K phosphorylation was measured immediately after washing (t = 0) and at 2 h, 4 h and 20 h after. Cells were similarly treated with rapamycin for comparison. All five chemicals inhibited the phosphorylation of p70S6K and p85S6K at Thr389 (Fig. 7a), as demonstrated above. Within 2 h following removal of perhexiline or niclosamide, mTORC1 signaling increased substantially and was fully restored by 4 h (Fig. 7a). Inhibition of mTORC1 signaling by rottlerin persisted for 2 h after drug removal but returned to control levels between 4 h and 20 h. By contrast, mTORC1 signaling remained completely inhibited 20 h after removal of amiodarone or rapamycin, indicating that these drugs act essentially irreversibly. Similarly, punctate EGFP-LC3 staining disappeared rapidly upon withdrawal of perhexiline, niclosamide and rottlerin, but not amiodarone, indicating reversible stimulation of autophagy for the former three compounds (Fig. 7b).
###end p 46
###begin title 47
Reversibility of mTORC1 inhibition and EGFP-LC3 punctate fluorescence accumulation.
###end title 47
###begin p 48
Cells were incubated for 4 h with 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone, 3 microM rottlerin, 20 nM rapamycin or DMSO. Drugs were washed away and cells were incubated in drug-free medium for the indicated times. (a) mTORC1 activity was measured by western blotting using phospho-specific and total S6K antibodies. beta-tubulin immunostaining was used as a gel loading control. (b) EGFP-LC3 punctate staining was measured using the automated microscopy assay.
###end p 48
###begin title 49
TSC2 is essential only for rottlerin-mediated inhibition of mTORC1 signaling
###end title 49
###begin p 50
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Tee1">[48]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Inoki1">[49]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Garami1">[50]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Tee2">[53]</xref>
TSC1/TSC2 plays an important role in the control of mTORC1 signaling. Insulin and growth factors have been proposed to turn on mTORC1 signaling through inactivation of TSC2 [48], [49], which functions as a GTPase-activating protein for the small G-protein Rheb [50]-[53].
###end p 50
###begin p 51
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 224 227 224 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang3">[54]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang3">[54]</xref>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 606 609 606 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 770 777 770 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g008">Fig. 8a</xref>
###xml 854 857 854 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 876 879 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 886 893 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g008">Fig. 8a</xref>
###xml 228 233 <span type="species:ncbi:10090">mouse</span>
Having established that perhexiline, niclosamide, amiodarone and rottlerin inhibit mTORC1 signaling, we sought to determine whether these drugs acted upstream of TSC2. To address this question we made use of TSC2-/- and TSC2+/+ mouse embryo fibroblasts also lacking both p53 alleles (hereafter referred to as TSC2-/- and TSC2+/+ MEFs) [54]. Near-confluent MEFs were incubated with each of the four chemicals or rapamycin in complete medium for 4 h and lysates were analysed for mTORC1 signaling. As originally reported by Zhang et al. [54], TSC2-/- MEFs exhibited elevated mTORC1 signaling relative to TSC2+/+ cells and in both cases rapamycin completely abolished mTORC1 signaling, in accordance with the fact that it inhibits mTORC1 signaling downstream of TSC1/TSC2 (Fig. 8a). Niclosamide, amiodarone and perhexiline inhibited mTORC1 signaling in TSC2+/+ as well as in TSC2-/- MEFs (Fig. 8a), indicating that TSC2 is not required for these drugs to inhibit mTORC1 signaling. These results imply that niclosamide, perhexiline and amiodarone inhibit mTORC1 signaling downstream of the tuberous sclerosis complex or through a different signaling cascade.
###end p 51
###begin title 52
Rottlerin inhibits mTORC1 signaling in a TSC2-dependent manner while perhexiline, niclosamide and amiodarone do not.
###end title 52
###begin p 53
###xml 8 11 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 205 208 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 216 219 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
(a) TSC2-/- or TSC2+/+ MEFs were incubated in complete medium with 10 microM perhexiline, 10 microM niclosamide, 3 microM rottlerin, 50 microM amiodarone, DMSO for 4 h or 100 nM rapamycin for 2 h. (b) TSC2-/- or TSC2+/+ MEFs were incubated in duplicate in complete medium with 4 microM rottlerin for 1 h, 100 nM rapamycin or DMSO for 30 min. Lysates were analysed by western blotting using the antisera indicated.
###end p 53
###begin p 54
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 115 118 115 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">64</sup>
###xml 140 150 140 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g008">Fig. 8a, b</xref>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 259 249 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g008">Fig. 8a, b</xref>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 571 574 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 674 684 674 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g008">Fig. 8a, b</xref>
Rottlerin also inhibited mTORC1 signaling in TSC2+/+ MEFs, as judged by the decreased phosphorylation of S6K at Thr389 and 4E-BP1 at Ser64 (Fig. 8a, b). However, unlike the other drugs, rottlerin failed to inhibit mTORC1 signaling in TSC2-/- cells (Fig. 8a, b), suggesting that it inhibits mTORC1 signaling by activating TSC2. The observation that rottlerin failed to inhibit mTORC1 signaling in TSC2-/- cells provided an opportunity to test whether it induces autophagy through inhibition of mTORC1 signaling. Rottlerin caused LC3II accumulation in both TSC2+/+ and TSC2-/- cells, indicating that inhibition of mTORC1 is not required for rottlerin-mediated LC3 processing (Fig. 8a, b).
###end p 54
###begin title 55
Niclosamide, rottlerin and perhexiline selectively kill MEFs in starvation conditions
###end title 55
###begin p 56
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 533 539 533 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 783 785 783 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 806 812 802 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 920 923 916 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 932 935 928 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 973 979 969 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 1083 1087 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Hosoi1">[55]</xref>
Having identified chemicals that stimulate autophagy and inhibit mTORC1 signaling, we next investigated their effect on cell survival and proliferation. TSC2+/+ and TSC2-/- MEFs were exposed to varying concentrations of the chemicals in complete medium. After 4 h, the chemicals were removed and the ability of the cells to recover and proliferate was monitored 48 h later. Incubation with niclosamide or rottlerin had no effect on viability or proliferation of MEFs, while perhexiline caused a small reduction in total cell number (Fig. 9). These results indicate that transient inhibition of mTORC1 signaling and stimulation of autophagy in complete medium had no adverse effect on subsequent cell survival or proliferation. Amiodarone was moderately toxic towards MEFs, with an IC50 of about 20 microM (Fig. 9), presumably resulting from acting on other cellular targets. Rapamycin decreased the proliferation of TSC2+/+ and TSC2-/- cells but did not induce cell death (Fig. 9), consistent with its known cytostatic activity and with its apparently irreversible mTORC1 inhibition [55].
###end p 56
###begin title 57
Effect of niclosamide, rottlerin, amiodarone and perhexiline on cell survival in different starvation conditions.
###end title 57
###begin p 58
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
TSC2-/- and TSC2+/+ MEFs were incubated for 4 h with different concentrations of the chemicals in complete medium or in the different starvation conditions shown. Chemicals and media were washed away and the cells were incubated for 40 h in complete medium without chemicals before measuring cell viability.
###end p 58
###begin p 59
###xml 68 74 68 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
This experiment was repeated using different starvation conditions (Fig. 9). Incubation of MEFs with DPBS (medium lacking glucose, amino acids and serum) for 4 h resulted in a small reduction in cell number at 48 h. Strikingly, addition of niclosamide or rottlerin in DPBS induced complete TSC2+/+ cell death. Perhexiline also caused TSC2+/+ cell death in DPBS, but only at high concentrations. Amiodarone showed moderate toxicity in complete medium but induced extensive cell death in DPBS. Supplementing DPBS with amino acids did not protect the cells from drug-induced death whereas supplementing with glucose increased survival considerably during exposure to niclosamide, rottlerin or amiodarone, and fully for perhexiline. Addition of both glucose and serum to DPBS rendered cells resistant to niclosamide, rottlerin and perhexiline. By contrast, rapamycin was not any more toxic to cells in DPBS or other starvation conditions than in complete medium.
###end p 59
###begin p 60
###xml 312 315 312 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 931 938 931 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g010">Fig. 10</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kroemer1">[56]</xref>
The observation that some chemicals that inhibit mTORC1 signaling and stimulate autophagy also selectively killed cells in starvation conditions was not anticipated given the established role of autophagy in promoting survival during starvation. Therefore, we next investigated the death mechanism involved. TSC2+/+ MEFs were exposed to chemicals for 4 h in complete medium or in starvation conditions. The drugs were then washed away and after 24 h, the cells were stained with FITC-Annexin V and propidium iodide. Annexin V binds to phosphatidylserine on the outer leaflet of the plasma membrane and labels cells actively undergoing apoptosis while propidium iodide is excluded by viable cells with an intact plasma membrane and therefore labels dead cells. Flow cytometry analysis revealed that in starvation conditions, the four chemicals caused a considerable increase in cells labeled with FITC-Annexin and propidium iodide (Fig. 10). Autophagic cell death is not associated with increased Annexin V binding [56], indicating that the chemicals trigger apoptotic cell death in starvation conditions.
###end p 60
###begin title 61
Effect of active chemicals on membrane integrity and apoptosis.
###end title 61
###begin p 62
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
TSC2+/+ MEFs were incubated for 4 h with DMSO or with 3 microM niclosamide, 30 microM amiodarone, 3 microM rottlerin or 10 microM perhexiline in the cell culture media indicated. Chemicals and media were washed away and the cells were incubated for 24 h in complete medium without chemicals. The extent of cell death and apoptosis was determined by measuring propidium iodide uptake (PI, y axis; relative fluorescence intensity measured in FL2 channel) and FITC Annexin V staining (x axis; relative fluorescence intensity measured in FL1 channel) by flow cytometry. Live cells (PI- and Annexin V-negative) appear in the lower left part of the scatter plots while cells that have died of apoptosis (PI- and Annexin V-positive) appear in the upper right hand part. The numbers in each box indicate the percent of dead or dying (PI- and/or Annexin V-positive) cells.
###end p 62
###begin title 63
TSC2 is an important determinant of cellular sensitivity to active chemicals in starvation conditions
###end title 63
###begin p 64
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 19 16 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 134 128 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 472 475 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 563 566 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 587 593 587 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007124-g009">Fig. 9</xref>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
TSC2+/+ and TSC2-/- MEFs responded similarly to each of the four chemicals in complete medium but not in starvation conditions (Fig. 9). TSC2-/- cells were generally more resistant than TSC2+/+ MEFs to exposure to niclosamide, rottlerin and perhexiline in the different starvation conditions. For example, exposure of TSC2-/- cells to niclosamide or rottlerin in DPBS strongly decreased cell survival but addition of glucose was sufficient to almost completely rescue TSC2-/- cell survival, whereas both glucose and serum were necessary to prevent killing of TSC2+/+ by these chemicals (Fig. 9). By contrast, the effect of rapamycin was similar in TSC2+/+ and TSC2-/- cells under all conditions, consistent with it acting downstream of TSC1/TSC2. These results show that the tuberous sclerosis complex plays an important role in the selective killing of cells by niclosamide, rottlerin and perhexiline in starvation conditions.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 1267 1270 1267 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
This study identifies four chemicals (perhexiline, niclosamide, amiodarone and rottlerin) that stimulate autophagy and inhibit mTORC1 signaling within a few hours in conditions of nutrient and growth factor sufficiency, under which autophagy is normally downregulated and mTORC1 signaling switched on. Each of the four chemicals showed interesting similarities to and differences from the well-characterized mTORC1 inhibitor rapamycin. Rapamycin inactivates mTORC1 very rapidly, within a few minutes of cellular exposure. Niclosamide also rapidly inhibits mTORC1 signaling but this inhibition is initially partial, complete inhibition being achieved after 1-2 h incubation. The three other chemicals required 1-2 h incubation to inhibit mTORC1 signaling, strongly implying that they do not inhibit mTORC1 directly, but target upstream mTORC1 control pathways. Rapamycin is highly potent, complete mTORC1 inhibition being achieved at low nanomolar concentrations. Niclosamide is also potent, with sub-micromolar activity while the other three chemicals inhibit mTORC1 at micromolar concentrations. Rapamycin inhibits mTORC1 independently of TSC1/TSC2, similar to amiodarone, perhexiline and niclosamide. By contrast, rottlerin can only inhibit mTORC1 signaling in TSC2+/+ cells, implying that it inhibits mTORC1 signaling upstream of TSC2. All four compounds selectively inhibit mTORC1 but not mTORC2 signaling, as does rapamycin.
###end p 66
###begin p 67
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Hosoi1">[55]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Patrick1">[57]</xref>
Notably, the chemicals identified in this study differ from rapamycin with respect to the reversibility of mTORC1 inhibition. Rapamycin inhibits mTORC1 signaling irreversibly [55]. By contrast, inhibition of mTORC1 signaling by niclosamide, perhexiline and rottlerin is reversed upon drug removal, while amiodarone is only slowly reversible. Pharmacologically, reversible inhibition is considered a favorable property, especially for drug targets whose activity is necessary for normal cellular functions, because prolonged inhibition caused by irreversible inhibitors can lead to severe side effects [57]. This property should facilitate the fine-tuning of chemical inhibition of mTORC1 signaling in cells or animals for studies of mechanism of action or therapeutic potential.
###end p 67
###begin p 68
The effects of transient exposure on cell proliferation and viability between the four compounds and rapamycin also differed considerably. Transient exposure to nanomolar concentrations of rapamycin caused long-lasting inhibition of cell proliferation, consistent with its irreversible mode of mTORC1 inhibition. By contrast, 4 h incubation with niclosamide, rottlerin and perhexiline at concentrations that were sufficient to profoundly inhibit mTORC1 signaling and stimulate autophagy had little or no effect on cell viability or proliferation in cell culture medium containing nutrients and serum. This result is consistent with the reversible nature of mTORC1 signaling inhibition by these chemicals and demonstrates that strong but transient inhibition of mTORC1 signaling and stimulation of autophagy are not deleterious to cells. The observation that amiodarone killed cells while niclosamide, perhexiline, rottlerin and rapamycin did not suggests that amiodarone acts on targets other than mTORC1 and autophagy to induce toxicity.
###end p 68
###begin p 69
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kroemer1">[56]</xref>
###xml 1020 1024 1020 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Galluzzi1">[58]</xref>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lockshin1">[59]</xref>
###xml 1435 1438 1435 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1914 1918 1914 1918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee1">[60]</xref>
###xml 2160 2163 2160 2163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2167 2170 2167 2170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2278 2281 2278 2281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 2285 2288 2285 2288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2306 2309 2306 2309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2313 2316 2313 2316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2443 2447 2443 2447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee1">[60]</xref>
The effects of short exposure to the four chemicals on cell survival and proliferation in starvation conditions also differed from those of rapamycin. Transient exposure to rapamycin did not kill cells but was cytostatic and affected equally cells in complete medium and in starvation conditions. By contrast, the four autophagy-stimulating chemicals all enhanced to varying degrees cell killing in starvation conditions, with niclosamide and rottlerin showing the most pronounced effect. Killing was rescued partially by glucose and totally by further addition of serum, indicating that an interplay between energy status sensing, growth factor signaling and drug action is important for cell death. This observation was unexpected because autophagy is a well-established survival response to starvation and we anticipated that stimulators of autophagy would increase cell survival in starvation conditions. However, a form of death termed type II or autophagic death has been attributed to unregulated autophagy [56], [58], [59]. It can be suggested that simultaneous exposure to multiple autophagy stimuli might overactivate autophagy and transform a normally protective response into a death mechanism. However this does not appear to be the case because dying cells showed the presence of phosphatidylserine on the outer leaflet of their plasma membrane, indicating that death occurred through apoptosis. The observation that TSC2-/- cells are very significantly, but not completely, protected from death in starvation firmly implicates the TSC1/TSC2 signaling cascade in the death mechanism. The interesting observation that rapamycin does not trigger cell death in starvation but that upstream inhibitors of mTORC1 signaling do indicates that death does not result from mTORC1 inhibition per se. Rather, it implies the involvement of a TSC2-dependent but mTORC1-independent cell survival pathway. Lee et al [60] showed that loss of TSC2 activates p53 and increases cell death in response to glucose starvation and that inactivation of mTORC1 by rapamycin protects TSC2 mutant cells from starvation-induced death. They did not observe this effect in TSC2-/- p53-/- cells, which responded similarly to rapamycin treatment and were as resistant to glucose starvation as TSC2+/+ p53-/- cells. Since TSC2-/- p53-/- cells were used in the present study, the death pathway we speculate upon must be distinct from that identified by Lee at al. [60].
###end p 69
###begin p 70
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Thoreen1">[61]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-GarciaMartinez2">[62]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Fan1">[63]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Serra1">[64]</xref>
Perhexiline, niclosamide, amiodarone and rottlerin most likely inhibit mTORC1 signaling by acting on upstream regulatory pathways, unlike the recently described inhibitors of mTORC1/2 Torin1 [61] and Ku-0063794 [62] and the dual PI3k/mTOR inhibitors PI-103 [63] and NVP-BEZ235 [64], which inhibit these kinases directly.
###end p 70
###begin p 71
###xml 334 335 315 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 400 404 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Soltoff1">[65]</xref>
###xml 614 618 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kojima1">[66]</xref>
###xml 690 694 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Inoki3">[67]</xref>
###xml 1086 1089 1067 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Rottlerin is a widely used pharmacological agent believed until recently to inhibit PKCpartial differential selectively. However, it has now been unequivocally shown that rottlerin does not inhibit this kinase. Rather, it inhibits potently several other kinases and enzymes including malate dehydrogenase, activates several types of K+ channels, and uncouples mitochondrial oxidative phosphorylation [65]. Consistent with its uncoupling activity, rottlerin has been reported to reduce cellular ATP levels, causing AMPK activation through a poorly understood signaling mechanism involving the tumor suppressor LKB1 [66]. AMPK phosphorylates and activates TSC2 to switch off mTORC1 signaling [67]. It is tempting to speculate that rottlerin inhibits mTORC1 signaling through the phosphorylation of Ser 1345 on TSC2 by AMPK. However, there are currently no antibodies available to study this phosphorylation on TSC2. Although it is possible that rottlerin stimulates autophagy via AMPK, TSC2 and mTORC1, this is unlikely to be the only mechanism because LC3 processing still occurs in TSC2-/- cells in which rottlerin does not inhibit mTORC1 signaling.
###end p 71
###begin p 72
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Anand1">[68]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Fairweather1">[69]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Fairweather1">[69]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Pax1">[70]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Pampori1">[71]</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Pampori2">[72]</xref>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Saz1">[73]</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Curnock1">[74]</xref>
###xml 1008 1012 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-MacDonald1">[75]</xref>
###xml 80 86 <span type="species:ncbi:9606">humans</span>
###xml 990 995 <span type="species:ncbi:9606">human</span>
Niclosamide is a salicylanilide antihelmintic drug that was approved for use in humans nearly 50 years ago [68], [69]. It was developed on the basis of activity in rodent models of parasitic worm infection rather than inhibition of a precise cellular target and its mode of action remains unclear. Niclosamide is believed to owe its antiparasitic effects to protonophoric activity [69], the ability of some chemicals to embed themselves within membranes and, via a continuous cycle, carry protons across membranes along their concentration gradient. Niclosamide and analogues inhibit glucose uptake by parasites, possibly by lowering the plasma membrane potential of tegument cells through protonophoric activity [70], [71]. Niclosamide can also uncouple mitochondrial oxidative phosphorylation in worms [72] but this is not considered relevant to antihelmintic activity in the anaerobic intestinal environment [73]. Niclosamide can also uncouple mitochondrial oxidative phosphorylation in human cells [74], [75], raising the possibility that it inhibits mTORC1 signaling and stimulates autophagy by lowering ATP levels in the cell. However, this is not the case because niclosamide treatment did not significantly decrease cellular ATP concentration (96.6+/-0.3% in niclosamide-treated cells versus 100.0+/-3.3% in control cells treated with DMSO) during 4 h incubation, and mTORC1 inhibition by niclosamide did not require TSC2.
###end p 72
###begin p 73
###xml 53 57 53 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Singh1">[76]</xref>
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kodama1">[77]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang4">[78]</xref>
###xml 179 184 <span type="species:ncbi:4932">yeast</span>
Amiodarone is an antianginal and antiarrhythmic drug [76] that exerts many pharmacological activities including blockage of multiple ion channels [77]. Interestingly, exposure of yeast to amiodarone in nutrient-rich medium causes a rapid change in gene expression pattern resembling that elicited by starvation and by rapamycin, prompting the authors to suggest that amiodarone interferes with nutrient sensing and regulatory networks by an uncharacterized mechanism [78]. Amiodarone inhibited mTORC1 in a TSC2-independent manner and killed cells in starvation conditions in a manner that was not affected by TSC2, suggesting that its mechanism of action differs from that of rottlerin or niclosamide.
###end p 73
###begin p 74
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Singh2">[79]</xref>
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee2">[80]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Ashrafian1">[81]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee2">[80]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee2">[80]</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Abozguia1">[82]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Inglis1">[83]</xref>
Perhexiline is an antianginal drug with multiple pharmacological activities [79]. It was originally designated as a calcium channel blocker but it shows no such activity at therapeutic concentrations [80], [81]. Rather, there is increasing evidence that it acts by inhibiting carnitine palmitoyltransferase, an enzyme that permits the entry of fatty acids into mitochondria [80]. This inhibition shifts myocardial substrate utilization from fatty acids to lactate and glucose, which increases ATP generation per unit oxygen consumed and exerts an oxygen sparing effect on the heart muscle[80], [82], [83]. No protonophoric, mitochondrial uncoupling, or protein kinase inhibition activity has been attributed to this drug. Perhexiline inhibited mTORC1 in a TSC2-independent manner but its effects in starvation were not as pronounced as those of rottlerin, niclosamide or amiodarone.
###end p 74
###begin p 75
###xml 338 342 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Lee2">[80]</xref>
###xml 344 348 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Pilcher1">[84]</xref>
###xml 422 426 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Pilcher1">[84]</xref>
###xml 880 884 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-WHOVBCDS88.631">[85]</xref>
###xml 886 890 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Merschjohann1">[86]</xref>
###xml 996 1000 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Merschjohann1">[86]</xref>
###xml 1367 1371 1323 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Mosbys1">[87]</xref>
###xml 1527 1531 1479 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang5">[88]</xref>
###xml 218 224 <span type="species:ncbi:9606">humans</span>
###xml 873 879 <span type="species:ncbi:9606">humans</span>
###xml 937 941 <span type="species:ncbi:10116">rats</span>
The four chemicals identified in this study should be useful pharmacological tools to manipulate mTORC1 signaling and autophagy in cells and in animal models of disease. Perhexiline can be administered continuously to humans for many years, with mean plasma concentrations of approximately2 microM without any significant adverse effects [80], [84]. Severe side effects do not occur at serum concentrations below 5 microM [84]. Perhexiline induced autophagosome accumulation in the 1-3 microM range and strong mTORC1 inhibition was seen at 10 microM during 4 h exposure, close to therapeutic concentrations. Niclosamide exerts its antiparasitic activity in the intestinal lumen and was not designed to be absorbed through the intestine. Nevertheless, it shows 10% oral bioavailability and micromolar serum concentrations are achieved after a single oral dose in animals or humans [85], [86]. Intravenous administration of niclosamide to rats gave rise to a peak plasma concentration of 25 microM [86]. Niclosamide very strongly inhibited mTORC1 signaling at concentrations as low as 1 microM. Therefore, therapeutic inhibition of mTORC1 signaling may be achievable using niclosamide or a derivative. Amiodarone can be administered safely for many years with a mean steady state plasma concentration of 2 microM. Peak plasma concentrations can be as high as 60 microM [87]. Amiodarone inhibited mTORC1 signaling at concentrations above 10 microM. Rottlerin is not an approved drug but it shows a low toxicity profile in rodents [88] and it inhibits mTORC1 signaling at 1 microM.
###end p 75
###begin p 76
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
The observation that drugs already approved for human use can reversibly inhibit mTORC1 and stimulate autophagy in vitro at concentrations that correspond to or are close to those observed in the circulation during treatment should greatly facilitate the preclinical and clinical testing of mTORC1 inhibition in indications such as tuberous sclerosis, diabetes, cardiovascular disease, protein misfolding diseases and cancer.
###end p 76
###begin title 77
Materials and Methods
###end title 77
###begin title 78
Chemicals
###end title 78
###begin p 79
Cell culture reagents were purchased from Invitrogen, unless stated otherwise. General laboratory chemicals were purchased from Sigma-Aldrich, Fisher Scientific and BDH Inc. The 3,584 chemicals used in the screen were composed of chemicals from the Prestwick, Sigma LOPAC, Microsource Spectrum and Biomol natural products collections, and provided by the Canadian Chemical Biology Network (). Perhexiline, amiodarone, niclosamide, rottlerin, chloroquine and bafilomycin A1 were also purchased from Sigma-Aldrich. Rapamycin was from Calbiochem, Hoechst 33342 from Invitrogen and paraformaldehyde from BDH.
###end p 79
###begin title 80
Plasmids and antibodies
###end title 80
###begin p 81
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Kabeya1">[22]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Tee1">[48]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Wang2">[34]</xref>
###xml 319 324 319 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37/46</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">70</sup>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">389</sup>
###xml 425 428 425 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">473</sup>
###xml 703 705 700 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">65</sup>
###xml 140 145 <span type="species:ncbi:9606">human</span>
The pEGFP-LC3 vector, previously described by Kabeya et al. [22], was a kind gift of Dr. Tamotsu Yoshimori (Osaka, Japan). pRK7 FLAG-tagged human TSC2 [48], was a generous gift from Dr. Andrew Tee (Cardiff, UK). Anti-4E-BP1 antibody was prepared by Dr. Josep Parra and is described in Wang et al. [34]. Anti-phospho Thr37/46 4E-BP1 (#9459), anti-phospho Thr70 4E-BP1 (#9455), anti-phospho Thr389 S6K (#9205), anti-phospho Ser473 Akt (#9271), anti-Akt (#9272), anti-eIF4E (#9742) and anti-eIF4G (#2498) antibodies were bought from Cell Signaling Technology (Massachusetts, USA). Anti-S6K C-18 (#230), anti-MAP LC3 H-50 (#28266), anti-TSC2 C-20 (#893), anti-beta-tubulin H-235 (#9104) and anti-phospho Ser65 4E-BP1 (#18091) antibodies were purchased from Santa Cruz Biotechnology, Inc. Anti-GFP antibody (#1814460) was from Roche. Anti-LC3 antibody was from Nanotools (#0260-100/LC3-2G6).
###end p 81
###begin title 82
Cell culture, transfection and starvation procedures
###end title 82
###begin p 83
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 14 11 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang3">[54]</xref>
###xml 1421 1425 1417 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Fonseca1">[39]</xref>
###xml 283 289 <span type="species:ncbi:9913">bovine</span>
###xml 753 759 <span type="species:ncbi:9913">bovine</span>
###xml 1230 1236 <span type="species:ncbi:9913">bovine</span>
###xml 1456 1462 <span type="species:ncbi:9913">bovine</span>
TSC2-/-/p53-/- and TSC2+/+/p53-/- MEFs were a generous gift of Dr. David Kwiatkowski (Massachusetts, USA) and have been previously described by Zhang et al. [54]. These cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum, 100 units/ml penicillin/streptomycin and 2 mM L-glutamine (Sigma-Aldrich). MCF-7 (Michigan Center Foundation line 7) cells were transfected with pEGFP-LC3 using Effectene transfection reagent (#301425, Invitrogen) according to the manufacturer's specification. Stably-transfected cells were selected for 2 months in RPMI-1640 medium supplemented with 400 microg/ml G418 (#V7982, Promega), 100 units/ml penicillin/streptomycin, 1 mM HEPES, 10% (v/v) foetal bovine serum and 2 g/L sodium bicarbonate. EGFP-LC3 expressing cells were sorted by fluorescence-activated cell sorter and pooled. The pooled cells were thereafter maintained in the RPMI-1640 medium described above and used for all experiments. For starvation experiments, cells were rinsed twice in DPBS (#14040, Invitrogen) before incubations in the different starvation media. Serum starvation was carried out by incubating cells in their corresponding medium lacking fetal bovine serum. Glucose starvation was carried out by incubating cells in Hank's Balanced Salt Solution (#37150, StemCell Technologies) or DPBS supplemented with amino acids from a 10x mixture [39] and 10% (v/v) dialysed foetal bovine serum. For amino acid starvation, cells were incubated for 4 h in either DPBS containing 11 mM glucose. Starvation of serum, glucose and amino acids was carried out by incubating cells in DPBS.
###end p 83
###begin title 84
Chemical screen for modulators of autophagy
###end title 84
###begin p 85
###xml 563 564 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 580 581 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 720 722 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TI</sup>
###xml 1729 1733 1692 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Zhang1">[26]</xref>
MCF-7 cells stably expressing EGFP-LC3 were seeded in PerkinElmer View 96-well plates at 20,000 cells per well. Eighteen hours after seeding, chemicals were added to each well to a final concentration of approximately15 microM using a Biorobotics Biogrid II robot equipped with a 0.7 mm diameter 96-pin tool. Plates were incubated for 4 h at 37degreesC. The medium was then removed and the cells were fixed with 3% (v/v) paraformaldehyde containing 500 ng/ml Hoechst 33342 for 15 min at room temperature. Fixed cells were washed once with PBS containing 1 mM MgCl2 and 0.1 mM CaCl2 and then stored in the same medium at 4degreesC until plates were ready for analysis. Plates were read in a Cellomicstrade markArrayscan VTI automated fluorescence imager. Cells were photographed using a 20x objective in the Hoechst and GFP (XF-100 filter) channels. The compartment analysis algorithm was used to identify the nuclei, apply a cytoplasmic mask and quantitate GFP spots in the GFP channel fixed at 250 pixel intensity units. Fluorescence intensity in the GFP channel was gated at 10 average pixel intensity units inside the cytoplasmic mask to select against cells expressing very low levels of EGFP-LC3. The total pixel intensity for punctate EGFP-LC3 was acquired as 'circ spot total intensity ch2'. Wells showing 3-fold or higher increase in punctate EGFP-LC3 staining over control were re-examined visually to eliminate any false positives resulting from precipitation of fluorescent compounds. Compounds inducing a 3-fold or higher increase in punctate EGFP-LC3 staining were considered 'hits'. Compounds causing a decrease in cell number to fewer than 4,000/well were disregarded as toxic chemicals. The Z-factor of the assay [26] was determined from punctate EGFP-LC3 measured in cells treated with DMSO (negative control) or chloroquine (positive control).
###end p 85
###begin title 86
Cell lysis and protein quantitation
###end title 86
###begin p 87
###xml 224 225 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 227 228 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cells were harvested in the following extraction buffer: 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% (v/v) Triton X100, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate supplemented with fresh 1 mM Na3VO4, 1 mM dithiothreitol and 1x complete protease inhibitor cocktail (#11697498001, Roche Molecular Biochemicals). Lysates were pre-cleared by centrifugation at 18,000 g for 15 min at 4degreesC. Supernatant was collected and protein quantitated using the BCA protein assay kit (#23227, Pierce).
###end p 87
###begin title 88
Viability/proliferation assay
###end title 88
###begin p 89
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Curman1">[89]</xref>
Cells were seeded in 96-well plates at 8000 cells per well and grown for 18 h. Cells were then treated with chemicals in different starvation media for 4 h as described above. The drugs and media were then removed and cells were incubated in complete medium without drugs. Cell viability/proliferation was measured 48 h later using the (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay (M2128, Sigma) as described [89].
###end p 89
###begin title 90
Flow cytometry
###end title 90
###begin p 91
###xml 312 313 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
After drug treatment, the cell culture medium was collected to retain floating cells and attached cells were dislodged using EDTA. Floating and attached cells were combined and harvested by centrifugation. The cell pellets were suspended in 100 microl binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) and incubated with 5 microl FITC Annexin V (BD Biosciences) and 10 microl of a propidium iodide solution (50 microg/ml; Sigma) for 15 min in the cold. Staining for Annexin V and propidium iodide was assessed by flow cytometry on a FACSCalibur instrument (BD Biosciences) followed by data analysis using FlowJo software (Tree Star Inc).
###end p 91
###begin title 92
SDS-PAGE and western blot
###end title 92
###begin p 93
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007124-Prick1">[90]</xref>
EGFP-LC3 processing was assayed by western blot as described [90]. TSC2 protein levels and S6K phosphorylation were analyzed by separating protein samples on a 10% acrylamide gel containing 0.1% methylene bisacrylamide. Endogenous LC3 lipidation and 4E-BP1 phosphorylation were assessed by resolving protein samples on a 13.5% acrylamide gel with 0.36% methylene bisacrylamide. Resolved protein was subjected to electroblotting onto polyvinylidene fluoride membrane, blocked with 5% (w/v) fat-free milk and incubated with antisera as indicated. Endogenous LC3 and 4E-BP1 proteins were cross-linked to the membrane with 0.2% (v/v) glutaraldehyde in PBS-0.02% (v/v) Tween20 for 30 min, following transfer and prior to the blocking step.
###end p 93
###begin title 94
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
m7GTP affinity chromatography
###end title 94
###begin p 95
###xml 159 160 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 448 483 434 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cell lysis and protein quantitation</italic>
###xml 516 517 502 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
200 microg of protein lysate from MCF-7 cells stably expressing EGFP-LC3 were incubated with 30 microl (neat) 7-methylguanosine-5'-triphosphate sepharose 4B (m7GTP) (#27-5025-01, GE Healthcare) for 90 min at 4degreesC, mixing end-over-end. Beads were then pelleted by centrifugation at low speed for 30 sec. Beads were washed twice with extraction buffer supplemented with protease and phosphatase inhibitors and dithiothreitol as described in the Cell lysis and protein quantitation section. Material bound to the m7GTP sepharose was then eluted by boiling for 10 min with 50 microl 5x sample buffer (200 mM Tris-HCl pH 6.8, 8% (w/v) sodium dodecyl sulphate, 0.4% (w/v) bromophenol blue, 40% (v/v) glycerol) containing 100 mM dithiothreitol. Eluted material was analysed by SDS-PAGE/immunoblot with anti-4E-BP1, anti-eIF4G and anti-eIF4G antibodies.
###end p 95
###begin title 96
Supporting Information
###end title 96
###begin p 97
Stimulation of punctate EGFP-LC3 accumulation and EGFP-LC3 processing by rapamycin. (a) MCF-7 cells expressing EGFP-LC3 were incubated with 20 nM rapamycin for the indicated times and images were acquired using the automated microscopy assay. (b) MCF-7 cells expressing EGFP-LC3 were treated in complete medium with 20 nM rapamycin for the indicated times. EGFP-LC3 processing was monitored by probing lysates with anti-GFP antibody and mTORC1 activity by probing lysates with antisera against phosphorylated (Thr389) S6K and total S6K. (c) Quantitation of punctate EGFP-LC3 staining during 4 h incubation in complete medium or amino acid and serum starvation using the screening assay.
###end p 97
###begin p 98
(0.71 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
Illustration of screening assay and results. (a) Data used for determination of Z-factor. Forty-eight wells were treated for 4 h with DMSO (negative control) and 48 wells were treated with chloroquine (positive control). Punctate EGFP-LC3 staining was determined using the screening assay. (b) Results from one 96-well plate of screening chemicals demonstrating quantitation of punctate EGFP-LC3 staining, with four positive controls (chloroquine) and two active chemicals indicated by blue arrows. The right panels show images obtained from the automated microscopy screen for an inactive chemical (top) and an active chemical (bottom).
###end p 100
###begin p 101
(0.25 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
Niclosamide, rottlerin, amiodarone and perhexiline inhibit the amino acid-dependent phosphorylation of 4E-BP1 at Thr37/46. MCF-7 cells stably expressing EGFP-LC3 were incubated in Hank's balanced salt solution supplemented with 10% (v/v) dialysed serum for 1 h or 4 h. Where indicated, cells were simultaneously incubated with 10 microM perhexiline, 10 microM niclosamide, 50 microM amiodarone, 3 microM rottlerin or 0.2% (v/v) DMSO for the times indicated. (a) Lysates were probed for EGFP-LC3 processing using GFP antibody. Tubulin staining was used as a loading control. (b) Lysates were probed for 4E-BP phosphorylation at Thr37/46 or total 4E-BP1 levels using the antisera indicated.
###end p 103
###begin p 104
(0.16 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
We thank Tamotsu Yoshimori, Andrew Tee, Josep Parra and David Kwiatkowski for their generous gifts of cells, antibodies and plasmids, and Hilary Anderson for critical reading of the manuscript.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Autophagy: a regulated bulk degradation process inside cells.
###end article-title 108
###begin article-title 109
###xml 38 43 <span type="species:ncbi:4932">yeast</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Methods for monitoring autophagy from yeast to human.
###end article-title 109
###begin article-title 110
TOR signaling in growth and metabolism.
###end article-title 110
###begin article-title 111
The mTOR pathway in the control of protein synthesis.
###end article-title 111
###begin article-title 112
Autophagy: Basic Principles and Relevance to Disease.
###end article-title 112
###begin article-title 113
Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin.
###end article-title 113
###begin article-title 114
Regulation of eIF-4E BP1 phosphorylation by mTOR.
###end article-title 114
###begin article-title 115
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.
###end article-title 115
###begin article-title 116
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.
###end article-title 116
###begin article-title 117
Role and regulation of starvation-induced autophagy in the Drosophila fat body.
###end article-title 117
###begin article-title 118
Tor-mediated induction of autophagy via an Apg1 protein kinase complex.
###end article-title 118
###begin article-title 119
###xml 149 173 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The Atg1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecific autophagy in Saccharomyces cerevisiae.
###end article-title 119
###begin article-title 120
Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.
###end article-title 120
###begin article-title 121
Nutrient-dependent mTORC1 Association with the ULK1-Atg13-FIP200 Complex Required for Autophagy.
###end article-title 121
###begin article-title 122
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes.
###end article-title 122
###begin article-title 123
###xml 68 73 <span type="species:ncbi:4932">yeast</span>
Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast.
###end article-title 123
###begin article-title 124
Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K pathway.
###end article-title 124
###begin article-title 125
The role of autophagy in cancer development and response to therapy.
###end article-title 125
###begin article-title 126
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?
###end article-title 126
###begin article-title 127
Potential therapeutic applications of autophagy.
###end article-title 127
###begin article-title 128
Atg8 controls phagophore expansion during autophagosome formation.
###end article-title 128
###begin article-title 129
###xml 30 35 <span type="species:ncbi:4932">yeast</span>
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
###end article-title 129
###begin article-title 130
The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway.
###end article-title 130
###begin article-title 131
A ubiquitin-like system mediates protein lipidation.
###end article-title 131
###begin article-title 132
Regulation and role of autophagy in mammalian cells.
###end article-title 132
###begin article-title 133
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.
###end article-title 133
###begin article-title 134
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
###end article-title 134
###begin article-title 135
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.
###end article-title 135
###begin article-title 136
###xml 103 108 <span type="species:ncbi:9606">human</span>
Rottlerin induces autophagy and apoptotic cell death through a PKC-delta-independent pathway in HT1080 human fibrosarcoma cells: the protective role of autophagy in apoptosis.
###end article-title 136
###begin article-title 137
Molecular mechanism and regulation of autophagy.
###end article-title 137
###begin article-title 138
Analyzing macroautophagy in hepatocytes and the liver.
###end article-title 138
###begin article-title 139
Autophagic clearance of aggregate-prone proteins associated with neurodegeneration.
###end article-title 139
###begin article-title 140
Role and regulation of autophagy in cancer.
###end article-title 140
###begin article-title 141
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
###end article-title 141
###begin article-title 142
A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1.
###end article-title 142
###begin article-title 143
Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytes.
###end article-title 143
###begin article-title 144
Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells.
###end article-title 144
###begin article-title 145
The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
###end article-title 145
###begin article-title 146
PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex.
###end article-title 146
###begin article-title 147
Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
###end article-title 147
###begin article-title 148
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
###end article-title 148
###begin article-title 149
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes.
###end article-title 149
###begin article-title 150
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
###end article-title 150
###begin article-title 151
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.
###end article-title 151
###begin article-title 152
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.
###end article-title 152
###begin article-title 153
###xml 64 69 <span type="species:ncbi:9606">human</span>
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer.
###end article-title 153
###begin article-title 154
Induction of autophagy and inhibition of tumorigenesis by beclin 1.
###end article-title 154
###begin article-title 155
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
###end article-title 155
###begin article-title 156
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
###end article-title 156
###begin article-title 157
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.
###end article-title 157
###begin article-title 158
Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.
###end article-title 158
###begin article-title 159
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
###end article-title 159
###begin article-title 160
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
###end article-title 160
###begin article-title 161
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.
###end article-title 161
###begin article-title 162
###xml 95 100 <span type="species:ncbi:9606">human</span>
Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
###end article-title 162
###begin article-title 163
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.
###end article-title 163
###begin article-title 164
An introduction to medicinal chemistry.
###end article-title 164
###begin article-title 165
Life, death and burial: multifaceted impact of autophagy.
###end article-title 165
###begin article-title 166
Apoptosis, autophagy, and more.
###end article-title 166
###begin article-title 167
Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.
###end article-title 167
###begin article-title 168
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.
###end article-title 168
###begin article-title 169
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
###end article-title 169
###begin article-title 170
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma.
###end article-title 170
###begin article-title 171
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
###end article-title 171
###begin article-title 172
Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta.
###end article-title 172
###begin article-title 173
Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues.
###end article-title 173
###begin article-title 174
TSC2 mediates cellular energy response to control cell growth and survival.
###end article-title 174
###begin article-title 175
Fasciolicides: efficacy, actions, resistance and its management.
###end article-title 175
###begin article-title 176
###xml 45 64 <span type="species:ncbi:6183">Schistosoma mansoni</span>
###xml 69 86 <span type="species:ncbi:6192">Fasciola hepatica</span>
Effect of closantel on intrategumental pH in Schistosoma mansoni and Fasciola hepatica.
###end article-title 176
###begin article-title 177
Cotugnia digonopora: carbohydrate metabolism and effect of anthelmintics on immature worms.
###end article-title 177
###begin article-title 178
Energy metabolism in Cotugnia digonopora and the effect of anthelmintics.
###end article-title 178
###begin article-title 179
Energy metabolisms of parasitic helminths: adaptations to parasitism.
###end article-title 179
###begin article-title 180
Inhibition of stimulated Jurkat cell adenosine 3',5'-cyclic monophosphate synthesis by the immunomodulatory compound HR325.
###end article-title 180
###begin article-title 181
###xml 65 70 <span type="species:ncbi:9606">human</span>
Identifying off-target effects and hidden phenotypes of drugs in human cells.
###end article-title 181
###begin article-title 182
Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
###end article-title 182
###begin article-title 183
Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.
###end article-title 183
###begin article-title 184
Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone.
###end article-title 184
###begin article-title 185
The mechanism of action of calcium antagonists relative to their clinical applications.
###end article-title 185
###begin article-title 186
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
###end article-title 186
###begin article-title 187
Perhexiline.
###end article-title 187
###begin article-title 188
Modification of myocardial substrate use as a therapy for heart failure.
###end article-title 188
###begin article-title 189
Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
###end article-title 189
###begin article-title 190
Investigations of long-term treatment with perhexiline maleate using therapeutic monitoring and electromyography.
###end article-title 190
###begin article-title 191
In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
###end article-title 191
###begin article-title 192
Neuroprotective effect of protein kinase Cdelta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.
###end article-title 192
###begin article-title 193
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine.
###end article-title 193
###begin article-title 194
###xml 3 8 <span type="species:ncbi:4932">yeast</span>
In yeast, loss of Hog1 leads to osmosensitivity of autophagy.
###end article-title 194
###begin p 195
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 195
###begin p 196
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Financial support for this study was obtained from the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 196

